Drug Extravasation Completed Phase 1 Trials for Aldesleukin (DB00041)

Also known as: Drug extravasations / Extravasation / Extravasation NOS / Extravasation (morphologic abnormality)

IndicationStatusPhase
DBCOND0029080 (Drug Extravasation)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004890Biomed 101 and Interleukin-2 in Treating Patients With Kidney CancerTreatment